Patient number |
58 |
117 |
|
Status Last follow-up |
|
|
|
Alive |
47 (81%) |
79 (67%) |
0.062 |
Dead |
11 (19%) |
38 (32%) |
|
Disease-related death |
4 (6.9%) |
20 (17%) |
0.066 |
Years surgery to death |
|
|
|
Mean ± SEM |
4.3 ± 1.3 |
8.1 ± 0.6 |
0.01 |
[range] |
[0.6-13.2] |
[0.6-20.7] |
|
Years surgery to disease-related death |
|
|
|
Mean ± SEM |
7.2 ± 1.9 |
7.1 ± 1.3 |
0.99 |
[range] |
[2.4-11.9] |
[0.6-20.7] |
|
Duration of follow-up (yrs) |
|
|
|
Time from surgery to last follow-up (yrs) |
|
|
|
Mean ± SEM |
9.5 ± 0.7 |
11.6 ± 0.6 |
|
[range] |
[0.1-21.8] |
[0.1-28.1] |
|
Time from onset ZES to last follow-up (yrs) |
|
|
|
Mean ± SEM |
18.8 ± 1.2 |
19.2 ± 0.9 |
|
[range] |
[4.2-49.5] |
[1.4-42.1] |
|
Postoperative status |
|
|
|
Disease-free |
|
|
|
Immediate Postop |
36 (63%) |
63 (54%) |
0.31 |
Last Followup |
28 (48%) |
41 (35%) |
0.09 |
Not disease free last followup |
30 (52%) |
76 (64%) |
0.09 |
Recurrence |
8 (14%) |
22 (19%) |
0.41 |
Liver metastases during follow-up |
|
|
|
No. developing liver metastases |
6 (10%) |
19 (17%) |
0.36 |
Time to development (yrs) |
|
|
|
Mean ± SEM |
3.7 ± 0.9 |
3.1 ± 0.6 |
|
[range] |
[0.8-7.2] |
[0.2-7.2] |
|
No. developing new lesions during follow-up |
12 (21%) |
48 (41%) |
0.008 |